The Food and Drug Administration inspected Mylan Pharmaceuticals, Inc. in Morgantown on April 28 to assess drug quality assurance, according to information on the FDA’s website.
The inspection’s final report found that no corrective actions were necessary for the company’s operational management.
The FDA regularly examines facilities nationwide to verify that work environments and products meet legal standards as part of its efforts to safeguard public health. These inspection outcomes are available to the public.
Per its website, the FDA is a federal agency that oversees the safety and quality of human and animal drugs, biological goods, medical devices, and tobacco products.
Information for this article comes from the U.S. Food and Drug Administration. The original data source can be accessed here.
